Answers are grounded in this paper and cite their sources.
Hepatic steatosis is defined as the accumulation of intrahepatic fat of at least 5% of liver weight, which may lead to metabolic dysfunction and inflammation in the liver. It is a common condition in 7% to 30% of people and gets worse over time into liver fibrosis, cirrhosis, and hepatocellular carcinoma. Modern science illustrates that there is no specific treatment protocol for fatty liver disease (FLD) except a healthy diet and exercise. In this case report, an individual was diagnosed with hepatosteatosis, having symptoms- pain in the abdomen with heartburn, burning in the throat, excessive thirst, belching, lassitude, constipation, nausea, and a yellowish appearance in the eyes. Fibroscan shows 77% of fat deposition with fibrosis (Grade F1). Based on the cardinal features of Udarashula, Chardi, and Peetanetra, the patient was assigned as a case of Parinam Shula and treated according to the line of management of Shula Chikitsa. After 3 months of drug intervention, there is a significant reduction in symptoms. Fibroscan shows a significant reduction in fat deposition (77% to 24%) with changes in fibrosis grading (from F1 to F0).
No takes yet. Share an insight, caveat, or question.
Upadhyay et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: